קם-רהו די

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

ANTI-D IMMUNOGLOBULINS

Pieejams no:

KAMADA LTD, ISRAEL

ATĶ kods:

J06BB01

Zāļu forma:

תמיסה להזרקה

Kompozīcija:

ANTI-D IMMUNOGLOBULINS 150 MCG / 1 ML

Ievadīšanas:

תוך-ורידי

Receptes veids:

מרשם נדרש

Ražojis:

KAMADA LTD, ISRAEL

Ārstniecības grupa:

ANTI-D (RH) IMMUNOGLOBULIN

Ārstniecības joma:

ANTI-D (RH) IMMUNOGLOBULIN

Ārstēšanas norādes:

Suppression of Rh immunization in non-sensitized Rho(D) negative women delivering an Rh positive baby, or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions, threatened abortion associated with maternal bleeding amniocentesis, chorionic villus sampling ruptured tubal pregnancy, and significant abdominal trauma. KAM-Rho should be given within 72 hours of event. Immune thrombocytopenic purpura (ITP): Rho (d)-positive adults with chronic ITP, children with chronic or acute ITP, and patients with Thrombocytopenia secondary to HIV infection in clinical situations requiring an increase in platelet count to prevent excessive hemorrhage.

Autorizācija datums:

2013-03-31